These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23039232)

  • 41. Activity-aware clustering of high throughput screening data and elucidation of orthogonal structure-activity relationships.
    Lounkine E; Nigsch F; Jenkins JL; Glick M
    J Chem Inf Model; 2011 Dec; 51(12):3158-68. PubMed ID: 22098146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging chemical patterns: a new methodology for molecular classification and compound selection.
    Auer J; Bajorath J
    J Chem Inf Model; 2006; 46(6):2502-14. PubMed ID: 17125191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of tyrosinase inhibition activity using atom-based bilinear indices.
    Marrero-Ponce Y; Khan MT; Casañola Martín GM; Ather A; Sultankhodzhaev MN; Torrens F; Rotondo R
    ChemMedChem; 2007 Apr; 2(4):449-78. PubMed ID: 17366651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Target family-directed exploration of scaffolds with different SAR profiles.
    Hu Y; Bajorath J
    J Chem Inf Model; 2011 Dec; 51(12):3138-48. PubMed ID: 22091691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioactivity landscape modeling: chemoinformatic characterization of structure-activity relationships of compounds tested across multiple targets.
    Waddell J; Medina-Franco JL
    Bioorg Med Chem; 2012 Sep; 20(18):5443-52. PubMed ID: 22178187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design of multitarget activity landscapes that capture hierarchical activity cliff distributions.
    Dimova D; Wawer M; Wassermann AM; Bajorath J
    J Chem Inf Model; 2011 Feb; 51(2):258-66. PubMed ID: 21275393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation and validation of the first predictive pharmacophore model for cyclin-dependent kinase 9 inhibitors.
    Fang C; Xiao Z; Guo Z
    J Mol Graph Model; 2011 Apr; 29(6):800-8. PubMed ID: 21333571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design of a three-dimensional multitarget activity landscape.
    de la Vega de León A; Bajorath J
    J Chem Inf Model; 2012 Nov; 52(11):2876-83. PubMed ID: 23113585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of multitarget activity ridges in high-dimensional bioactivity spaces.
    Gupta-Ostermann D; Bajorath J
    J Chem Inf Model; 2012 Oct; 52(10):2579-86. PubMed ID: 23004919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tag SNP selection using particle swarm optimization.
    Chuang LY; Yang CS; Ho CH; Yang CH
    Biotechnol Prog; 2010; 26(2):580-8. PubMed ID: 20039435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-based and property-compliant library design of 11β-HSD1 adamantyl amide inhibitors.
    Paderes GD; Dress K; Huang B; Elleraas J; Rejto PA; Pauly T
    Methods Mol Biol; 2011; 685():191-215. PubMed ID: 20981525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimization of the MAD algorithm for virtual screening.
    Eckert H; Bajorath J
    Methods Mol Biol; 2008; 453():349-62. PubMed ID: 18712313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitors.
    Griebenow N; Flessner T; Buchmueller A; Raabe M; Bischoff H; Kolkhof P
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2554-8. PubMed ID: 21396815
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AMPSO: a new particle swarm method for nearest neighborhood classification.
    Cervantes A; Galvan IM; Isasi P
    IEEE Trans Syst Man Cybern B Cybern; 2009 Oct; 39(5):1082-91. PubMed ID: 19336325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SAR matrices: automated extraction of information-rich SAR tables from large compound data sets.
    Wassermann AM; Haebel P; Weskamp N; Bajorath J
    J Chem Inf Model; 2012 Jul; 52(7):1769-76. PubMed ID: 22657271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel tricyclic inhibitors of IKK2: discovery and SAR leading to the identification of 2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-7-yl)pyridin-2-yl)methyl)acetamide (BMS-066).
    Watterson SH; Langevine CM; Van Kirk K; Kempson J; Guo J; Spergel SH; Das J; Moquin RV; Dyckman AJ; Nirschl D; Gregor K; Pattoli MA; Yang X; McIntyre KW; Yang G; Galella MA; Booth-Lute H; Chen L; Yang Z; Wang-Iverson D; McKinnon M; Dodd JH; Barrish JC; Burke JR; Pitts WJ
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7006-12. PubMed ID: 22018461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BRUTUS: optimization of a grid-based similarity function for rigid-body molecular superposition. 1. Alignment and virtual screening applications.
    Tervo AJ; Rönkkö T; Nyrönen TH; Poso A
    J Med Chem; 2005 Jun; 48(12):4076-86. PubMed ID: 15943481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conditional probabilities of activity landscape features for individual compounds.
    Vogt M; Iyer P; Maggiora GM; Bajorath J
    J Chem Inf Model; 2013 Jul; 53(7):1602-12. PubMed ID: 23789585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of hits and lead structure candidates with limited resources by adaptive optimization.
    Schüller A; Schneider G
    J Chem Inf Model; 2008 Jul; 48(7):1473-91. PubMed ID: 18590273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.